Information  X 
Enter a valid email address

BioPharma Credit PLC (BPCR)

  Print      Mail a friend

Tuesday 28 August, 2018

BioPharma Credit PLC

Notice of Interim Results

RNS Number : 0035Z
BioPharma Credit PLC
28 August 2018
 

28 August 2018

 

BIOPHARMA CREDIT PLC

("The Company")

 

NOTICE OF INTERIM RESULTS

 

BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt investor, will announce its audited Half Year Results for the period ending 30 June 2018, on Thursday 27 September 2018.

A management presentation will be delivered at 11:30 through a conference call facility, to request conference call details, RSVP to [email protected].

-Ends-

 

Enquiries

 BioPharma Credit PLC

via Link Company Matters Limited

Company Secretary

+44 (0) 1392 477 500

 

Buchanan

+44 (0)20 7466 5000

David Rydell / Mark Court / Jamie Hooper / Henry Wilson

[email protected]

 

Notes to Editors:

BioPharma Credit PLC is London's only listed specialist investor in debt from the life sciences industry and joined the LSE on 27 March 2017. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.

LEI: 213800AV55PYXAS7SY24

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NORKVLBLVVFEBBX

a d v e r t i s e m e n t